Overview

A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

Status:
Terminated

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to observe and evaluate the change in renal function following conversion from cyclosporine-based immunosuppressive regimen to tacrolimus-based one.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Korea, Inc.

Treatments:

Cyclosporine
Cyclosporins
Immunosuppressive Agents
Tacrolimus